Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases

2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases

US Patent 11111217 · Granted Sep 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds2025
Compounds for activating a serotonin receptor2025
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative disea2025
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative disea2025
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative disea2025
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative disea2025
Systems, devices, and methods for DLT-based data management platforms and data p2024
Sustained release olanzapine formulations2023
Antibody adjuvant conjugates2023
Methods for cancer treatment2023
Systems, devices, and methods for DLT-based data management platforms and data p2022
Immunoconjugates targeting HER22022